HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Studies on pathophysiology of schizophrenia with a rare variant as a clue].

Abstract
Schizophrenia is a relatively common and severe mental disorder with complex inheritance patterns; its main manifestations are hallucinations, delusions, and disorganized speech and thinking. The exact etiology of schizophrenia remains unsolved, although pharmacological and biological studies have proposed several hypothetical disease mechanisms and plausible candidate genes for susceptibility. Since the early nineties, extensive genetic studies have been performed on this illness, but there has been no marked progress in the research, and reproducible results have not yet been obtained. Such difficulties in genetic studies of schizophrenia arise from the heterogeneity of this disease. Candidate gene approaches are based on the common disease-common variant hypothesis. However, there is no guarantee that a common variant is shared by patients with heterogeneous pathophysiologies of this disorder. We studied a rare mutation with a major alteration in genetic function based on the common disease-rare variant hypothesis. We detected a novel frameshift mutation of glyoxalase 1 (GLO1) accompanied by a 50% reduction in enzymatic activities in a male schizophrenic patient belonging to a pedigree with multiple affected individuals. GLO1 detoxifies toxic carbonyl compounds that produce advanced glycation end products (AGEs) such as pentosidine by Maillard reaction. AGEs accumulate because of carbonyl stress caused by an increase in reactive carbonyl compounds and their attendant protein modifications. A significant increase in plasma AGEs and a low serum pyridoxal level was seen in our patient. In addition, we found other patients with schizophrenia characterized by the presence of homozygotes of the Ala allele of Glu111Ala in the GLO1 gene and a 16% reduction in the activities that showed high plasma AGEs. As compared to that of the 61 control patients, 45 patients with schizophrenia yielded significantly high levels of AGEs in the plasma and low serum pyridoxal levels. Our findings suggest that GLO1 deficits and carbonyl stress are linked to the development of a certain subtype of schizophrenia. Elevated plasma pentosidine and concomitant low vitamin B₆ levels can be the most cogent and easily measurable biomarkers in schizophrenia and can prove to be helpful for classifying heterogeneous schizophrenia on the basis of biological causes.
AuthorsMasanari Itokawa, Makoto Arai, Tomoe Ichikawa, Mitsuhiro Miyashita, Yuji Okazaki
JournalBrain and nerve = Shinkei kenkyu no shinpo (Brain Nerve) Vol. 63 Issue 3 Pg. 223-31 (Mar 2011) ISSN: 1881-6096 [Print] Japan
PMID21386123 (Publication Type: Journal Article, Review)
Chemical References
  • Glycation End Products, Advanced
  • Lactoylglutathione Lyase
Topics
  • Frameshift Mutation
  • Glycation End Products, Advanced (metabolism)
  • Humans
  • Lactoylglutathione Lyase (genetics)
  • Male
  • Schizophrenia (genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: